Document:

Exhibit 10.6

 

Senior Advisor Agreement

 

This Agreement is entered into by and between Lightlake Therapeutics
Inc. (the “Company”) and Brad Miles (“Miles”) (collectively, the “Parties”) on January 22,
2013 (the “Agreement”).

 

WHEREAS Miles is a Senior Advisor to the Company;

 

WHEREAS the Company has requested that Miles provide additional
services beneficial to the Company beyond the scope of what Miles has previously provided to the Company (the “Services”);

 

WHEREAS Miles has received compensation deemed by the Company
to be inadequate to retain Miles as a Senior Advisor;

 

WHEREAS the Company seeks to retain Miles as a Senior Advisor;
and

 

WHEREAS the Company seeks to provide Miles with additional incentive
to remain a Senior Advisor and perform the Services;

 

NOW THEREFORE, in consideration of the mutual covenants herein
contained, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Parties
hereby mutually agree as follows:

 

		1)	Miles shall provide the Services until one (1) year from the date hereof.

 

		2)	Any compensation granted herein shall be in addition to any other option compensation previously granted by the Company to
Miles. Notwithstanding the foregoing, all options previously granted by the Company to Miles with an exercise price above $0.12
shall be cancelled and deemed ineffective on the date hereof and be surrendered to the Company within thirty (30) days of the date
hereof.

 

		3)	Miles shall be granted stock options for one million seven hundred and fifty thousand (1,750,000) shares of stock of the Company,
exercisable at US$0.15 (“Exercise Price”) with the life of such options being five (5) years (collectively, the “Options”).
Such Options shall be exercisable in the form of Notice of Stock Option Grant attached as Exhibit A hereto, which Options may be
exercised, where applicable, pursuant to the form of Notice of Exercise of Stock Option (the “Exercise Notice”) attached
as Exhibit B hereto. Notwithstanding any provisions of the Options to the contrary, if the fair market value of one share of Common
Stock (as defined in the Stock Option Plan of the Company effective December 15, 2010 (the “Stock Option Plan”)) is
greater than the exercise price (at the date of calculation as set forth below), in lieu of exercising the Options for cash, the
Holder (as defined in the Stock Option Plan) may elect to receive shares equal to the value (as determined below) of the Options
(or the portion thereof being exercised) by surrender of the Options at the principal office of the Company together with the properly
signed Exercise Notice in which event the Company shall issue to the Holder a number of shares of Common Stock computed using the
following formula:

 

     

     

    

 

	X=	Y(A-B)	 
	 	A	 
	 	 	 
	Where X =	the number of shares of Common Stock to be issued to the Holder
	 	 
	Y =	the number of shares of Common Stock purchasable under the Options or, if only a portion of the Options are being exercised, the portion of the Options being exercised (at the date of such calculation)
	 	 
	A =	the fair market value of one share of the Company’s Common Stock (at the date of such calculation)
	 	 
	B =	
        the Exercise Price per share (as adjusted to the date of such
        calculation)

        

 

Notwithstanding the foregoing, such Options may only
be exercised between the following dates: (i) the earliest date on which the price per share of the Company’s Common Stock
has traded at or above US$0.30 for at least three (3) trading days out of any ten (10) consecutive trading days; and (ii) their
expiration date. Proportionate adjustments shall automatically be made to both the Exercise Price and number of such Options, and
the price per share restriction set forth in this paragraph, in the event of a stock split, stock dividend, reclassification, recapitalization,
or any other increase or decrease in the number of issued shares of the Company’s Common Stock effected without receipt of
consideration by the Company, or upon any other event reasonably determined by a majority of the Board of Directors of the Company
to justify such adjustments.

 

Within one (1) month following the date hereof, the
Company shall deliver to Miles all Options granted herein. All such Options delivered to Miles as per this Agreement may be delivered
to Miles electronically with a scanned signature, in which case they shall have the same effect and force as if they had been delivered
in original signed form. For all Options granted to Miles electronic delivery of a signed Exercise Notice along with electronic
delivery of such Options shall have the same exercise effect as surrendering such Options at the principal office of the Company
together with the properly signed Exercise Notice.

 

     

     

    

  

		4)	In the event of termination of this Agreement, the Company shall not be obligated to provide any further compensation to Miles.

 

		5)	This Agreement shall be governed by and construed in accordance with the laws of the United States, and specifically the laws
of the state of Nevada. Should a dispute arise, both parties shall subject themselves to exclusive jurisdiction of the courts of
the state of Nevada.

 

		6)	This Agreement constitutes the entire understanding between the Parties relating to its subject matter, superseding all negotiations,
prior discussions, preliminary agreements and agreements relating to the subject matter hereof made prior to the date hereof. No
waiver by a Party of any breach by another Party of any term, provision or condition of this Agreement, to be performed by such
other Party shall be deemed a waiver of similar or dissimilar provisions or conditions at the same time or at any prior or subsequent
time. This Agreement may not be modified or amended except in writing signed by the Parties. Each of the Parties hereto agrees
that this Agreement has been jointly prepared, and that no claim may be asserted by any Party that any ambiguity in this Agreement
may be construed against any one Party.

 

		7)	This Agreement may be executed in counterparts, each of which shall constitute an original but together shall constitute one
and the same Agreement. The Parties further agree that such counterparts may be provided via scan, email, and/or facsimile to one
another, each of which shall be binding upon the signatory who sends the scan, email and/or facsimile that was signed by such sending
signatory. The Parties further agree to exchange the original signature pages hereof as soon as practicable after sending such
scan, email and/or facsimile, but in any dispute or controversy, the Parties hereto agree that it shall not be necessary for any
such Party to provide the original signature pages of the other as a condition of enforcing this Agreement, it being understood
that such scan, email and/or facsimile signature pages shall be sufficient to establish the consent of the Party who sent the scan,
email and/or facsimile that was signed by such sending signatory to be bound by the terms of this Agreement.

 

		8)	This Agreement does not include any appropriate compensation that the Company would be obligated to provide Miles as a result
of the relationships Miles developed with Pfizer Inc., AstraZeneca, and Purdue Pharma L.P. that result in a financial strategic
partnership where any or all of the Company's treatments would receive funding to move clinical trials forward.

 

     

     

    

  

IN WITNESS WHEREOF the parties have executed
this Agreement this 22 day of January 2013.

 

 

LIGHTLAKE THERAPEUTICS INC.

 

	By:	/s/ Roger Crystal	 
	Name:	Roger Crystal	 
	Title:	CEO	 

 

 

 

	By:	/s/ Brad Miles	 
	Name:	Brad Miles	 
	Title:	Senior Advisor	 

 

 

     

     

    

EXHIBIT A

 

FORM OF NOTICE OF STOCK OPTION GRANT

 

 

Dear Brad Miles (“Optionee”),

 

Reference is hereby made to (i) the Stock Option Plan of Lightlake
Therapeutics Inc. (the “Company”) effective December 15, 2010 (the “Stock Option Plan”),
and (ii) the Senior Advisor Agreement dated January 22, 2013 between the Company and Brad Miles (as amended, restated, or otherwise
modified from time to time, the “Letter”). Capitalized terms utilized herein shall have the meanings ascribed
to them in the Stock Option Plan unless otherwise defined herein.

 

You have been granted
options to purchase Common Stock of the Company (with each share of Common Stock of the Company, a “Share”)
as follows:

 

	 	Board Approval Date:	 
	 	 	 
	 	Date of Grant:	 
	 	 	 
	 	Exercise Price per Share:	US$0.15
	 	 	 
	 	Total Number of Shares Granted:	1,750,000
	 	 	 
	 	Total Exercise Price:	Cashless exercise as per the Letter
	 	 	 
	 	Type of Options:	Non-Qualified Stock Options
	 	 	 
	 	Expiration Date:	The date that is five (5) years from the Date of Grant
	 	 	 
	 	Termination Period:	These Options may be exercised for a period of five (5) years from the Date of Grant.  Optionee is responsible for keeping track of these exercise periods following termination for any reason of his service relationship with the Company, it being understood that Optionee is entitled to all rights, including compensation and vesting rights, with respect to this Option, as set forth in the Letter.  The Company will not provide further notice of such periods.
	 	 	 
	 	Transferability:	These Options may not be transferred, except as permitted by applicable laws and regulations.
	 	 	 
	 	Restrictions on Exercise:	These Options may only be exercised between the following dates: (i) the earliest date on which the price per Share has traded at or above US$0.30 for at least three (3) trading days out of any ten (10) consecutive trading days; and (ii) the Expiration Date.  Notwithstanding anything to the contrary contained in any agreement with the Company, it is an absolute condition of the Optionee’s right to exercise any Option that the Optionee be in full compliance with any other agreements between the Optionee and the Company, including without limitation any confidentiality agreements.
	 	 	 
	 	Vesting:	100% on the date of the Senior Advisor Agreement referenced herein

 

     

     

    

 

Following receipt by
the Company of evidence and/or an indemnity from the Optionee to the Company in a form reasonably satisfactory to the Company of
the loss, theft, destruction or mutilation of these Options or any certificates for representing the Shares underlying these Options
and, in the event of mutilation, following the surrender and cancellation of such Options or stock certificate, the Company will
make and deliver replacement Options or stock certificate of like tenor and dated as of such cancellation, in lieu of these Options
or stock certificates, without any charge therefor, it being understood that the making and/or delivery of such replacement Options
or stock certificates by the Company will not be unreasonably withheld.  Any such replacement Options or stock certificates
shall be subject to the same terms, conditions, and restrictions as these Options and any Shares underlying these Options. Proportionate
adjustments shall automatically be made to both the Exercise Price and number of these Options, and the Restrictions on Exercise,
in the event of a stock split, stock dividend, reclassification, recapitalization, or any other increase or decrease in the number
of issued Shares of the Company effected without receipt of consideration by the Company, or upon any other event reasonably determined
by a majority of the Board of Directors of the Company to justify such adjustments.

 

To the extent that the
terms of the Stock Option Plan differ from the terms of this Notice of Stock Option Grant (the “Notice”), the
terms of this Notice supersede the terms of the Stock Option Plan.

 

By your signature and
the signature of the Company’s representative below, you and the Company agree to the terms of these Options.

 

	BRAD MILES	 	LIGHTLAKE THERAPEUTICS INC.
	 	 	 
	 	 	 
	Optionee	 	Roger Crystal, Chief Executive Officer

 

     

     

    

 

EXHIBIT B

 

Form of Notice of Exercise of Stock
Option

 

Ladies and Gentlemen:

 

This letter constitutes an unconditional
and irrevocable notice that I hereby exercise the stock option(s) granted to me by Lightlake Therapeutics Inc., a Nevada corporation
(the “Company”) on _______________ at a fair market value of US$ ______ per share. Pursuant to the terms of
such option(s), I wish to purchase _______________ shares of the common stock covered by such option(s) at the exercise price(s)
of US$ ______ per share via cashless exercise. These shares should be registered under the Securities Act of 1933, as amended,
and delivered as follows:

 

	Name:	 	 
	 	 	 
	Address: 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	Social Security Number: 	 	 

 

I represent that I will not dispose of such
shares in any manner that would involve a violation of applicable securities laws.

 

	Dated:  	 	 	By: 	 	 
	 	 	 	 	 	 
	 	 	 	
        Name:Exhibit 10.7

 

First Amendment to
Senior Advisor Agreement

 

This amendment (the “First
Amendment”) to the Senior Advisor Agreement by and between Brad Miles (“Miles”) and Lightlake Therapeutics Inc.
(the “Company”) dated January 22, 2013 (the “Agreement”) is entered into on February 24, 2015, and hereby
amends the terms of the Agreement.

 

WHEREAS Miles is a Senior
Advisor to the Company;

 

WHEREAS the Company has
requested that Miles provide additional Services (as defined in the Agreement);

 

WHEREAS Miles has received
compensation deemed by the Company to be inadequate to retain Miles as a Senior Advisor;

 

WHEREAS the Company seeks
to retain Miles as a Senior Advisor; and

 

WHEREAS the Company seeks
to provide Miles with additional incentive to remain a Senior Advisor and perform the Services;

 

NOW THEREFORE, in consideration
of the mutual covenants herein contained, and other good and valuable consideration, the receipt and sufficiency of which is hereby
acknowledged, the Parties hereby mutually agree to this First Amendment as follows:

 

		1)	Miles shall provide the Services to the Company until December 31, 2016 (the “Term End Date”),
unless the Agreement is terminated as per the terms of the Agreement or the terms herein.

 

		2)	Any compensation granted herein to Miles shall be in addition to any other option compensation
previously granted by the Company to Miles.

 

		3)	Until the Term End Date the Company shall pay Miles Ten Thousand United States Dollars (US$10,000.00)
for each calendar quarter that Miles provides Services to the Company (the “Quarterly Payment”), unless the Agreement
is terminated as per the terms of the Agreement or the terms herein. The first Quarterly Payment shall be paid to Miles within
three (3) business days of the date of this Amendment. Unless the Agreement is terminated as per the terms in the Agreement or
the terms herein, subsequent Quarterly Payments shall be paid to Miles within twenty (20) business days of April 1, 2015, July
1, 2015, October 1, 2015, January 1, 2016, April 1, 2016, July 1, 2016, and October 1, 2016. All Quarterly Payments due to Miles
shall be wired to Miles according to the following instructions:

 

     

     

    

 

Brad Miles

 

117 Sandcherry
Court

 

Pickering,
Ontario Canada, L1V 6V8

 

Bank of Montreal

 

726 Kingston
Rd., Unit 1

 

Pickering
West

 

Pickering
Ontario Canada, L1V 1A9

 

Account#:

 

Swift Code:

 

Routing#:

 

		4)	The following language in Paragraph 3 of the Agreement:

 

“Such
Options shall be exercisable in the form of Notice of Stock Option Grant attached as Exhibit A hereto, which Options may be exercised,
where applicable, pursuant to the form of Notice of Exercise of Stock Option (the “Exercise Notice”) attached as Exhibit
B hereto.”

 

is hereby
deleted and replaced with the following language:

 

“Exercise
of these Options shall occur by Miles’s: (i) surrendering the exercised Options at the then current official address listed
in securities filings of the Company together with a properly completed and signed Notice of Exercise of Stock Option (as per Exhibit
B), and (ii) providing via email a readable .pdf or scan of all of the documentation set forth in (i) to the following email addresses:
roger.crystal@lightlaketherapeutics.com and kevin.pollack@lightlaketherapeutics.com.”

 

		5)	Miles shall follow all Company policies and procedures and comply with all laws and regulations.

 

		6)	The Agreement may be terminated at any time by the Company effective immediately by written or
electronic notice by the Company, if Miles:

 

(a)        Commits
any serious breach, or repeat (after previous written warning, which warning may be provided via email) of any breach, or is guilty
of a continuing breach of any of the terms of the Agreement; or

 

(b)        Is
guilty of any serious misconduct or willful neglect in the discharge of Miles’s obligations under the Agreement; or

 

     

     

    

 

(c)        Is
declared bankrupt; or

 

(d)        Is
convicted of any criminal offense (except minor traffic violations), which the Board of Directors of the Company (the “Board”)
reasonably believes materially and/or adversely affects Miles’s ability to continue; or

 

(e)        Is
convicted of any offense relating to insider dealing or any serious breach of any of the laws or regulations, as determined by
the Board; or

 

(f)        Is
the subject of, or cause the Company to be the subject of, a serious penalty or reprimand imposed by any regulatory authority by
which the Company is governed or to which its activities are subject; or

 

(g)       Engages
in any act of moral turpitude, including, but not limited to, an act of dishonesty, theft, or misappropriation of Company property,
insubordination, or any act injuring, abusing, or endangering others, as determined by the Board.

 

		7)	In the event of termination of the Agreement, the Company shall not be obligated to provide any
further compensation to Miles.

 

		8)	The Company and Miles each agrees to release, indemnify and hold harmless the other party from
and against any third party claims for any loss, damages, liability, costs, or expenses, including reasonable attorney fees, arising
from or relating to any negligence, wrongful acts or omissions by the other party or their respective officers, directors or employees.

 

		9)	During the course of Miles’s engagement as a Senior Advisor, from time to time, Miles is
likely to obtain knowledge of trade secrets and other confidential information with regard to the business and financial affairs
of the Company and its subsidiaries, whether currently existing or not, (together the “Group”) and its customers’
and suppliers’ details, and Miles has obtained such information while rendering past Services to the Company (collectively,
the “Confidential Information”). Accordingly, Miles shall not (except in the proper course of his duties hereunder)
at any time (such obligation continuing indefinitely), divulge any Confidential Information to any person, firm, corporation, or
entity whomsoever other than as required by law or legal or similar proceedings, or as required to conduct the duties and responsibilities
set forth in the Agreement. Miles shall use his best endeavors to prevent the unauthorized publication or disclosure of Confidential
Information, and shall not use for his own purposes, or for any purposes other than those of the Company Confidential Information
(which have come to Miles’s knowledge while rendering past Services to the Company and that may come to Miles’s knowledge
during or in the course of the engagement hereunder or Miles’s engagement with any subsidiary of the Company). Such Confidential
Information shall, without limitation, be deemed to include the following:

 

     

     

    

 

(a)       Any
knowledge or information relating to any trade secret, process, invention, or concerning the business or finances of the Group
or any dealings relating thereto;

 

(b)        Transactions
or affairs of any of the Group, or of any officers, directors, shareholders, or employees of the Group, or any other information
of a confidential character (including such information belonging to or relating to any third party);

 

(c)        Any
information concerning the structure and format of the Group’s products, promotions, and services;

 

(d)        Any
confidential business methods of the Group;

 

(e)        Any
confidential pricing information or any information relating to prospective or actual tenders for contracts with prospective or
actual suppliers or customers of the Group;

 

(f)        Any
confidential client or customer lists of the Group; and

 

(g)        Any
document or data of the Group marked confidential or which Miles might reasonably expect to be of a confidential nature.

 

All
articles, notes, sketches, computer programs, plans, memoranda, records, and any other documents (whether in hard or electronic
form) or copies thereof provided to, created or used by Miles in relation to any Confidential Information shall be and remain the
property of the Company, or the relevant subsidiary of the Company, and shall be delivered together with all copies thereof, to
the Company or as it shall direct from time-to-time, on demand, promptly after the Term End Date, or immediately when the Agreement
is terminated.

 

The obligations
in this Paragraph 9 shall not apply to information that is in the public domain other than by reason of breach of this Paragraph
9.

 

Miles’s
obligations under this Paragraph 9 shall, with respect to each subsidiary of the Company, whether currently existing or not, constitute
a separate and distinct covenant in respect of which Miles hereby covenant with the Company as trustee for each such other company.

 

Each of the sub-paragraphs
of this Paragraph 9 shall be separate, distinct, and severable from each other. In the event that any of the sub-paragraphs is
held void but would be valid if any part of the wording thereof were deleted, such restriction shall apply with such deletions
as may be necessary to make it valid and effective.

 

     

     

    

  

		10)	This First Amendment, together with any other documents incorporated herein by reference, including
the Agreement, and related exhibits and schedules, constitutes the sole and entire agreement of the parties with respect to the
subject matter contained herein, and supersedes all prior and contemporaneous understandings, agreements, representations and warranties,
both written and oral, with respect to such subject matter.

  

		11)	The Agreement, as amended by this First Amendment, may only be amended, modified or supplemented
by an agreement in writing signed by each party hereto, and any of the terms thereof may be waived, only by a written document
signed by each party to the Agreement or, in the case of waiver, by the party or parties waiving compliance.

 

		12)	This First Amendment shall be governed by and construed in accordance with the internal laws of
the State of New York without giving effect to any choice or conflict of law provision or rule. Each party irrevocably submits
to the exclusive jurisdiction and venue of the federal and state courts located in New York in any legal suit, action or proceeding
arising out of or based upon this First Amendment or the Services and/or compensation provided hereunder.

 

		13)	If any term or provision of this First Amendment is invalid, illegal or unenforceable in any jurisdiction,
such invalidity, illegality or unenforceability shall not affect any other term or provision of this First Amendment or invalidate
or render unenforceable such term or provision in any other jurisdiction

 

		14)	This First Amendment may be executed in multiple counterparts and by facsimile signature or by
email of a PDF document, each of which shall be deemed an original and all of which together shall constitute one instrument.

 

     

     

    

 

IN WITNESS
WHEREOF the parties have executed this First Amendment this 24th day of February 2015.

 

 

LIGHTLAKE
THERAPEUTICS INC.

 

BY: /s/
Kevin Pollack

 

Name: Kevin
Pollack

 

Title: CFO

 

Address: 445
Park Avenue, 9th Floor, New York, NY 10022

 

Email Addresses
(for electronic Notice): Both kevin.pollack@lightlaketherapeutics.com and roger.crystal@lightlaketherapeutics.com

 

 

BRAD MILES

 

/s/ Brad
Miles

 

Federal Tax
Id. No./Social Security No.: N/A

 

Email Address
(for electronic Notice):

 

Address:
117 Sandcherry Court, Pickering, Ontario Canada, L1V 6V8

 

Phone Number:
905-509-2372

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00268-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00268-of-00352.parquet"}]]